Injectable ContraceptionROY, Geneviève.Seminars in reproductive medicine. 2010, Vol 28, Num 2, pp 126-132, 7 p.Article

Antitumor effects of combination toremifene and medroxyprogesterone acetate (MPA) in vitro and in vivoKANGAS, L; GROÊNROOS, M.Journal of steroid biochemistry. 1990, Vol 36, Num 3, pp 253-257, issn 0022-4731, 5 p.Conference Paper

Patient satisfaction of Depot Medroxyprogesterone Acetate (dmpa-sc) injection as contraceptiveCHAUDHRI, Rizwana; RIZVI, Farwa; AFZAL, Muhammad et al.Journal of the Pakistan Medical Association. 2010, Vol 60, Num 7, pp 536-540, issn 0030-9982, 5 p.Article

Treatment of seizures with medroxyprogesterone acetate: preliminary reportMATTSON, R. H; CRAMER, J. A; CALDWELL, B. V et al.Neurology. 1984, Vol 34, Num 9, pp 1255-1258, issn 0028-3878Article

Use of liquid chromatography in the synthesis of isoluminol-labelled medroxyprogesterone acetate and zeranolKOEHLER, H; LAROCQUE, L; SVED, S et al.Journal of chromatography. 1989, Vol 469, pp 305-315, issn 0021-9673, 11 p.Article

Sleep apnoea syndrome treated with oestradiol and cyclic medroxyprogesteroneFRANKLIN, K; LUNDGREN, R; RABBEN, T et al.Lancet (British edition). 1991, Vol 338, Num 8761, pp 251-252, issn 0140-6736, 2 p.Article

Immunosuppressive Biological Mechanisms Support Reassessment of Use of the Injectable Contraceptive Medroxyprogesterone AcetateHAPGOOD, Janet P.Endocrinology (Philadelphia). 2013, Vol 154, Num 3, pp 985-988, issn 0013-7227, 4 p.Article

Reversed-phase high-performance liquid chromatography with isocratic elution of 6α-methyl-17α-acetoxyprogesterone (MAP) and its impuritiesRAVINALE, E; ROSSO, A.Journal of chromatography. 1985, Vol 330, Num 2, pp 415-419, issn 0021-9673Article

The food and drug administration and medroxyprogesterone acetate. What are the issues? = Food and Drug Administration et acétate de médroxyprogestéroneROSENFIELD, A; MAINE, D; ROCHAT, R et al.JAMA, the journal of the American Medical Association. 1983, Vol 249, Num 21, pp 2922-2928, issn 0098-7484Article

The Cushing syndrome induced by medroxyprogesterone acetateSIMINOSKI, K; GOSS, P; DRUCKER, D. J et al.Annals of internal medicine. 1989, Vol 111, Num 9, pp 758-760, issn 0003-4819, 3 p.Article

Effect of medroxyprogesterone acetate on liver collagen and drug metabolism in rats after chemical liver injurySAARNI, H. U; SAVOLAINEN, E.-R; SOTANIEMI, E. A et al.Research communications in chemical pathology and pharmacology. 1983, Vol 42, Num 1, pp 61-69, issn 0034-5164Article

TRAITEMENT DE L'HIRSUTISME PAR PRISE ORALE D'ACETATE DE MEDROXYPROGESTERONE. A PROPOS DE 36 OBSERVATIONS, DONT 29 FOIS EN ASSOCIATION A UN ESTROGENEBUVAT J; LATTEUX MG; COLLIER F et al.1981; GYNECOLOGIE; ISSN 0301-2204; FRA; DA. 1981 PUBL. 1982; VOL. 32; NO 4-5; PP. 325-330; BIBL. 21 REF.Article

BLOOD LEVELS OF MEDROXYPROGESTERONE ACETATE AFTER MULTIPLE INJECTIONS OF DEPOPROVERA OR CYCLOPROVERAKOETSAWANG S; SHRIMANKER K; FOTHERBY K et al.1979; CONTRACEPTION; USA; DA. 1979; VOL. 20; NO 1; PP. 1-4; BIBL. 3 REF.Article

Radiosensitizing effect of medroxyprogesterone acetate on endometrial cancer cells in vitroHUBER, H; HUSSLEIN, P; MICHALICA, W et al.Cancer. 1984, Vol 54, Num 6, pp 999-1001, issn 0008-543XArticle

Medroxyprogesterone acetate in non-metastatic gestational trophoblastic diseaseGOLDBERG, G. L; CLOETE, K; BLOCH, B et al.British journal of obstetrics and gynaecology (Print). 1987, Vol 94, Num 1, pp 22-25, issn 0306-5456Article

MEDROXYPROGESTERONE, IMMUNOSUPPRESSION, AND CONCEPTUS SIZE IN PEROMYSCUSBELL FE; PALMER JS; DAWSON WD et al.1983; JOURNAL OF EXPERIMENTAL ZOOLOGY; ISSN 0022-104X; USA; DA. 1983; VOL. 226; NO 2; PP. 273-279; BIBL. 30 REF.Article

Influence of sex steroids and prolactin on haloperidol-induced catalepsyNICOLETTI, F; FERRARA, N; PATTI, F et al.Brain research. 1983, Vol 279, Num 1-2, pp 352-358, issn 0006-8993Article

HORMONE TREATMENT OF ADVANCED RENAL CELL CARCINOMARAGHAVAIAH NV.1982; UROLOGY (RIDGEWOOD); ISSN 0090-4295; USA; DA. 1982; VOL. 19; NO 2; PP. 123-126; BIBL. 33 REF.Article

Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetateCLARK, M. Kathleen; SOWERS, Maryfran; LEVY, Barcey et al.Fertility and sterility. 2006, Vol 86, Num 5, pp 1466-1474, issn 0015-0282, 9 p.Article

Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetateCLARK, M. Kathleen; SOWERS, Maryfran R; NICHOLS, Sara et al.Fertility and sterility. 2004, Vol 82, Num 6, pp 1580-1586, issn 0015-0282, 7 p.Article

A stability-indicating HPLC method for medroxyprogesterone acetate in bulk drug and injection formulationBURANA-OSOT, Jankana; UNGBORIBOONPISAL, Sooksri; SRIPHONG, Lawan et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 40, Num 5, pp 1068-1072, issn 0731-7085, 5 p.Article

Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraceptionCAMERON, Sharon T; GLASIER, Anna; JOHNSTONE, Anne et al.Contraception (Stoneham). 2012, Vol 85, Num 5, pp 458-464, issn 0010-7824, 7 p.Article

Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of the dosing intervalSMIT, Jennifer; BOTHA, Julia; MCFADYEN, Lynn et al.Contraception (Stoneham). 2004, Vol 69, Num 1, pp 3-7, issn 0010-7824, 5 p.Article

Current options for injectable contraception in the United StatesKAUNITZ, Andrew M.Seminars in reproductive medicine. 2001, Vol 19, Num 4, pp 331-337Article

L'acétate de médroxyprogestérone dans le traitement hormonal substitutif de la ménopause : Une revue succincte = Medroxyprogesterone acetate and hormone replacement therapy in menopausal women : A brief reviewGASPARD, U. J.Médecine et hygiène. 1996, Vol 54, Num 2127, pp 1507-1513, issn 0025-6749, 5 p.Article